Todd Golub, MD

Broad Institute, Dana-Farber Cancer Institute, Harvard Medical School

Todd Golub, a world leader in applying genomic tools to the classification and study of cancers, is a founding member of the Broad Institute and serves as Director of its Cancer Program. His work focuses on using the human genome to understand the biological and clinical challenges facing cancer medicine. He has made fundamental discoveries in the molecular basis of childhood leukemia, and pioneered the use of genomic approaches, particularly DNA microarrays, to cancer biology.

In 1997, Dr. Golub joined the Whitehead Institute/Massachusetts Institute of Technology Center of Genome Research, now part of the Broad Institute, as Director of its program in cancer research. Dr. Golub also serves as Chief Scientific Officer of the Broad Institute. He is the Charles A. Dana Investigator in Human Cancer Genetics at the Dana-Farber Cancer Institute, an investigator at Howard Hughes Medical Institute and professor of pediatrics at Harvard Medical School.

Dr. Golub is the recipient of multiple awards, including the 2009 AACR Richard and Hinda Rosenthal Memorial Award, the 2008 E. Mead Johnson Award from the Society for Pediatric Research, the 2007 Oski Prize of the American Society of Pediatric Hematology-Oncology, Discover Magazine’s Inventor of the Year (Health Category), the Daland Prize of the American Philosophical Society, the Outstanding Achievement Award for the American Association for Cancer Research and the 2007 Paul Marks Prize for Cancer Research. Dr. Golub also serves as Chairman of the Board of Scientific Advisors of the National Cancer Institute. Dr. Golub received his B.A. in 1985 from Carleton College and his M.D. in 1989 from the University of Chicago Pritzker School of Medicine.